Zobrazeno 1 - 10
of 4 468
pro vyhledávání: '"K, Blennow"'
Autor:
B.N. Lizama, H.A. North, K. Pandey, C. Williams, D. Duong, E. Cho, V. Di Caro, L. Ping, K. Blennow, H. Zetterberg, J. Lah, A.I. Levey, M. Grundman, A.O. Caggiano, N.T. Seyfried, M.E. Hamby
Publikováno v:
Neurobiology of Disease, Vol 199, Iss , Pp 106575- (2024)
CT1812 is a novel, brain penetrant small molecule modulator of the sigma-2 receptor (S2R) that is currently in clinical development for the treatment of Alzheimer's disease (AD). Preclinical and early clinical data show that, through S2R, CT1812 sele
Externí odkaz:
https://doaj.org/article/6d00f43c2b9e41fda59027091db73805
Autor:
A. Jeppsson, Å. Sandelius, A. Zettergren, S. Kern, I. Skoog, K. Blennow, H. Zetterberg, C. Wikkelsø, P. Hellström, M. Tullberg
Publikováno v:
Fluids and Barriers of the CNS, Vol 20, Iss 1, Pp 1-8 (2023)
Abstract Background Neurofilament light chain protein (NFL), a marker of neuronal axonal degeneration, is increased in cerebrospinal fluid (CSF) of patients with idiopathic normal pressure hydrocephalus (iNPH). Assays for analysis of NFL in plasma ar
Externí odkaz:
https://doaj.org/article/b04f5fdf546d4ad4ab16755ac118f9de
Autor:
K. Minta, G. Brinkmalm, S. Janelidze, S. Sjödin, E. Portelius, E. Stomrud, H. Zetterberg, K. Blennow, O. Hansson, U. Andreasson
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-11 (2020)
Abstract Background The human APOE gene, which codes for apolipoprotein E (apoE), has three major polymorphic alleles: ε2, ε3, and ε4 that give rise to amino acid substitutions. APOE-ε4 is a strong risk factor of sporadic Alzheimer’s disease (A
Externí odkaz:
https://doaj.org/article/1cc063aa72d2400893123db4cd563d4b
Autor:
J.P. Posti, V.F. Newcombe, N.J. Ashton, B. Glocker, A. Mankletow, D.A. Chatfield, S. Winzeck, E. Needham, M.M. Correia, G.B. Williams, J. Simrén, R.S. Takala, A.J. Katila, H.-R. Maanpää, J. Tallus, J. Frantzén, K. Blennow, O. Tenovuo, H. Zetterberg, D.K. Menon
Publikováno v:
Brain and Spine, Vol 2, Iss , Pp 101310- (2022)
Externí odkaz:
https://doaj.org/article/2f5ec0c28b7a4e199a66d3d49e9068c8
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-6 (2019)
Abstract Background We aimed to assess the relationship between levels of a cerebrospinal fluid (CSF) marker of pericyte damage, soluble platelet-derived growth factor receptor β (sPDGFRβ) and CSF markers of blood-brain barrier (BBB) integrity (CSF
Externí odkaz:
https://doaj.org/article/cf7184b084034452a39d048f2f9113db
Autor:
I. Hossain, M. Mohammadian, H.-R. Maanpää, R. Takala, O. Tenovuo, J. Frantzén, P. Hutchinson, D. Menon, V. Newcombe, K. Blennow, J.-C. Sanchez, H. Zetterberg, J. Posti
Publikováno v:
Brain and Spine, Vol 1, Iss , Pp 100615- (2021)
Externí odkaz:
https://doaj.org/article/8032db722cec4d33a6e8b8f98f208678
Autor:
Y.-Y. Chen, B. Gardiner, F. Pasztor, K. Blennow, J. Ryder, A. Valade, K. Naudts, J. Otto, M. J. McGrath, C. Planque, S. Luyssaert
Publikováno v:
Geoscientific Model Development, Vol 11, Pp 771-791 (2018)
Earth system models (ESMs) are currently the most advanced tools with which to study the interactions among humans, ecosystem productivity, and the climate. The inclusion of storm damage in ESMs has long been hampered by their big-leaf approach, w
Externí odkaz:
https://doaj.org/article/5cdd9ee2212146d0b9dd548f291edc60
Autor:
S.B. Hendrix, H. Soininen, A. Solomon, P.J. Visser, A.M.J. van Hees, D.S. Counotte, J. Nicodemus-Johnson, S.P. Dickson, K. Blennow, M. Kivipelto, T. Hartmann
Publikováno v:
JPAD-Journal of prevention of alzheimers disease. Editions SERDI
Journal of Prevention of Alzheimer's Disease. Springer International Publishing AG
LipiDiDiet clinical study group 2023, ' Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer’s Disease : Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial ', Journal of Prevention of Alzheimer's Disease, vol. 10, no. 3, pp. 464-470 . https://doi.org/10.14283/jpad.2023.29
Journal of Prevention of Alzheimer's Disease. Springer International Publishing AG
LipiDiDiet clinical study group 2023, ' Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer’s Disease : Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial ', Journal of Prevention of Alzheimer's Disease, vol. 10, no. 3, pp. 464-470 . https://doi.org/10.14283/jpad.2023.29
The LipiDiDiet randomized clinical trial is evaluating the long term effects of a multinutrient intervention (Fortasyn Connect) compared with control in participants with prodromal AD. In this post-hoc analysis we used the Alzheimer's Disease Composi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899964e2e64300e0d727f01dd9a81a5f
https://cris.maastrichtuniversity.nl/en/publications/41a1a530-5420-48b5-b81a-9e37adde34a6
https://cris.maastrichtuniversity.nl/en/publications/41a1a530-5420-48b5-b81a-9e37adde34a6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.